A detailed history of Quest Partners LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 11,763 shares of SAGE stock, worth $78,106. This represents 0.02% of its overall portfolio holdings.

Number of Shares
11,763
Previous 10,277 14.46%
Holding current value
$78,106
Previous $193 Million 33.67%
% of portfolio
0.02%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$10.58 - $17.9 $15,721 - $26,599
1,486 Added 14.46%
11,763 $128 Million
Q1 2024

May 09, 2024

SELL
$18.62 - $26.95 $32,491 - $47,027
-1,745 Reduced 14.52%
10,277 $193 Million
Q4 2023

Feb 09, 2024

BUY
$17.1 - $22.26 $205,576 - $267,609
12,022 New
12,022 $261 Million

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $395M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.